The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Reduced Inter- and Intraindividual Variability in Cyclosporine Pharmacokinetics from a Microemulsion Formulation
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical Pharmacokinetics of Cyclosporin
Ptachcinski, R. J., Venkataramanan, R., & Burckart, G. J. (1986) · Clinical Pharmacokinetics · doi:10.2165/00003088-198611020-00002 · Cited by 493
In Vitro Model for Ciclosporin Intestinal Absorption in Lipid Vehicles
Reymond, J.-P., & Sucker, H. (1988) · Pharmaceutical Research · doi:10.1023/a:1015987223407 · Cited by 85
Drug Absorption and Disposition: Statistical Considerations
Albert, K. S. (1981) · Medical Entomology and Zoology · Cited by 71
Cyclosporin absorption from microemulsion formulation in liver transplant recipient
Trull, A. K., Tan, K., Uttridge, J. A., Bauer, T., Alexander, G., & Jamieson, N. V. (1993) · The Lancet · doi:10.1016/0140-6736(93)93025-v · Cited by 63
In Vivo Model for Ciclosporin Intestinal Absorption in Lipid Vehicles
Reymond, J.-P., Sucker, H., & Vonderscher, J. (1988) · Pharmaceutical Research · doi:10.1023/a:1015939307478 · Cited by 47
Cited by
Microemulsion-based media as novel drug delivery systems
Lawrence, M. J., & Rees, G. D. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00103-4 · Cited by 2,040
Strategies to Address Low Drug Solubility in Discovery and Development
Williams, H. D., Trevaskis, N. L., Charman, S. A., Shanker, R. M., Charman, W. N., Pouton, C. W., & Porter, C. J. H. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.005660 · Cited by 1,570
Constantinides, P. P. (1995) · Pharmaceutical Research · doi:10.1023/a:1016268311867 · Cited by 742
Enhancing intestinal drug solubilisation using lipid-based delivery systems
Porter, C. J. H., Pouton, C. W., Cuine, J. F., & Charman, W. N. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.10.014 · Cited by 690
Formulation of self-emulsifying drug delivery systems
Pouton, C. W. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00490-5 · Cited by 624
Lipid-based vehicles for the oral delivery of poorly water soluble drugs
Humberstone, A. J., & Charman, W. N. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00494-2 · Cited by 577
50 years of oral lipid-based formulations: provenance, progress and future perspectives
Feeney, O. M., Crum, M. F., McEvoy, C. L., Trevaskis, N. L., Williams, H. D., Pouton, C. W., Charman, W. N., Bergström, C. A. S., & Porter, C. J. H. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.007 · Cited by 426
Lipid – An emerging platform for oral delivery of drugs with poor bioavailability
Chakraborty, S., Shukla, D., Mishra, B., & Singh, S. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2009.06.001 · Cited by 411
Khoo, S.-M., Humberstone, A. J., Porter, C. J. H., Edwards, G. A., & Charman, W. N. (1998) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(98)00054-4 · Cited by 396
Positively charged nanoparticles for improving the oral bioavailability of cyclosporin-A
El-Shabouri, M. H. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00461-1 · Cited by 392
Wu, C.-Y., Benet, L. Z., Hebert, M. F., Gupta, S. K., Rowland, M., Gomez, D. Y., & Wacher, V. J. (1995) · Clinical Pharmacology & Therapeutics · doi:10.1016/0009-9236(95)90168-x · Cited by 356
Oral delivery of proteins and peptides: Challenges, status quo and future perspectives
Zhu, Q., Chen, Z., Paul, P. K., Lu, Y., Wu, W., & Qi, J. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.04.001 · Cited by 353
Oral delivery of macromolecular drugs: Where we are after almost 100 years of attempts
Moroz, E., Matoori, S., & Leroux, J.-C. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.01.010 · Cited by 336
Microemulsion formulation for enhanced absorption of poorly soluble drugs
Kawakami, K., Yoshikawa, T., Moroto, Y., Kanaoka, E., Takahashi, K., Nishihara, Y., & Masuda, K. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00049-4 · Cited by 306
Microemulsions: A Novel Approach to Enhanced Drug Delivery
Talegaonkar, S., Azeem, A., Ahmad, F., Khar, R., Pathan, S., & Khan, Z. (2008) · Recent Patents on Drug Delivery & Formulation · doi:10.2174/187221108786241679 · Cited by 303
Buya, A. B., Beloqui, A., Memvanga, P. B., & Préat, V. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12121194 · Cited by 301
Aguirre, T. A. S., Teijeiro-Osorio, D., Rosa, M., Coulter, I. S., Alonso, M. J., & Brayden, D. J. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.02.004 · Cited by 299
Dunn, C. J., Wagstaff, A. J., Perry, C. M., Plosker, G. L., & Goa, K. L. (2001) · Drugs · doi:10.2165/00003495-200161130-00006 · Cited by 276
Kawakami, K. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.10.009 · Cited by 259
Using Microemulsions: Formulation Based on Knowledge of Their Mesostructure
Gradzielski, M., Duvail, M., de Molina, P. M., Simon, M., Talmon, Y., & Zemb, T. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00812 · Cited by 257
Thomas, N., Holm, R., Garmer, M., Karlsson, J. J., Müllertz, A., & Rades, T. (2013) · The AAPS Journal · doi:10.1208/s12248-012-9433-7 · Cited by 144
Pathak, R., Prasad Dash, R., Misra, M., & Nivsarkar, M. (2014) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2014.02.002 · Cited by 113
Iwanaga, K., Kushibiki, T., Miyazaki, M., & Kakemi, M. (2006) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.29.508 · Cited by 38
Metadata
- Authors
- Kovarik, J. M., Mueller, E. A., Kutz, K., Van Bree, J. B., & Tetzloff, W.
- Venue
- Journal of Pharmaceutical Sciences
- Publisher
- Elsevier BV
- Published
- 1994-03
- Volume
- 83
- Issue
- 3
- Pages
- 444-446
- ISSN
- 0022-3549 (ISSN-L)
- OpenAlex
- W2028293443
- Cited by
- 294
- References
- 5
- FWCI
- 22.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.